55% Covidshield recipients had mild side effects: AMCH study
|
||||
You Might Like💡 newsR Knowledge: Other News MentionsOxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca1 in 3 Covaxin recipients hit by adverse events: StudyNearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The..IndiaTimes Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP Credit: Oneindia Duration: 02:44Published |